- Report
- January 2023
- 32 Pages
Russia
From €2726EUR$2,995USD£2,315GBP
- Report
- February 2021
- 321 Pages
South Korea
From €5456EUR$5,995USD£4,634GBP
- Report
- February 2021
- 322 Pages
Italy
From €5456EUR$5,995USD£4,634GBP
- Report
- June 2023
- 132 Pages
Global
From €865EUR$950USD£734GBP
- Report
- November 2021
- 66 Pages
Global
€4323EUR$4,750USD£3,672GBP
- Report
- July 2024
- 351 Pages
Global
From €1692EUR$1,859USD£1,437GBP
€2416EUR$2,655USD£2,052GBP
- Report
- March 2022
- 180 Pages
Global
From €2275EUR$2,499USD£1,932GBP
€3249EUR$3,570USD£2,760GBP
- Book
- September 2021
- 1184 Pages
- Book
- November 2022
North America
- Book
- April 2022
- 560 Pages

Orthobiologics is a field of biotechnology that focuses on the development of products and treatments to improve musculoskeletal health. It includes the use of biological materials such as stem cells, growth factors, and proteins to repair, regenerate, and replace damaged or diseased tissues. Orthobiologics is used to treat a variety of musculoskeletal conditions, including fractures, tendon and ligament injuries, and degenerative joint diseases. It is also used to improve the healing of bone and soft tissue after surgery.
Orthobiologics is a rapidly growing field, with new products and treatments being developed to improve patient outcomes. It is becoming increasingly important in the treatment of musculoskeletal conditions, as it offers a more natural and less invasive approach than traditional treatments.
Some companies in the Orthobiologics market include Acelity, AlloSource, Arthrex, Bioventus, DePuy Synthes, Exactech, Integra LifeSciences, Medtronic, MiMedx, Orthofix, and Stryker. Show Less Read more